RetinalGenix Technologies (RTGN) Equity Average (2020 - 2026)

RetinalGenix Technologies has disclosed Equity Average across 7 years of filings, most recently posting -$2.4 million for Q1 2026.

• Equity Average for Q1 2026 came in at -$2.4 million, down 55.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 55.27% YoY), and the FY2025 annual result was -$1.9 million, down 31.27% from the prior year.
• Equity Average came in at -$2.4 million for Q1 2026 at RetinalGenix Technologies, down from -$2.2 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of -$594499.0 in Q1 2022 to a low of -$2.4 million in Q1 2026.
• The 5-year median for Equity Average is -$1.6 million (2025), against an average of -$1.5 million.
• Across the five-year window, Equity Average sank 382.26% in 2022 and retreated 1.65% in 2024, its largest moves.
• RetinalGenix Technologies' Equity Average stood at -$1.1 million in 2022, then slipped by 16.92% to -$1.2 million in 2023, then plunged by 33.31% to -$1.7 million in 2024, then sank by 34.92% to -$2.2 million in 2025, then retreated by 8.61% to -$2.4 million in 2026.
• The last three Equity Average figures came in at -$2.4 million (Q1 2026), -$2.2 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.